Headlines

Why Is Penny Stock Cognition Therapeutics Trading Over 93% On Wednesday?

Cognition Therapeutics’ CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional decline in trials.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *